NL-OMON38610撤回不适用
Validation of the 'Suicidality: Treatment Occuring in Paediatrics (STOP) Suite of Measures' in Clinical and Non-clinical Child and Adolescent Populations - STOP study
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Children and adolescents between the ages of 8 and 18 years old, and their parents or main carer.
- •Children and adolescents newly treated with an antidepressant or cognitive behavior therapy for depression or antipsychotic medication for any indication (this inclusion criteria is for clinical population only).
- •All parents and patients have provided informed consent/assent in accordance with ethical regulations.
排除标准
- •If the main carer does not have a reasonable level of Dutch, they will be excluded from the study. This is because a reasonable level of Dutch is required to complete the baseline information.
- •Children who are deemed by the clinician to be too vulnerable to participate (for clinical population only).
- •The child/adolescent will be excluded if the main carer is not available to participate in the study.
研究者
相似试验
招募中
1 期
VECTORS – A study to evaluate transmural healing as a treatment target in Crohn’s diseaseModerately to Severely Active Crohn’s DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856CTIS2023-509096-16-00Alimentiv Inc.266
招募中
2 期
A Clinical Trial To Evaluate The Effectiveness Of Vasa Avaleha In Respiratory Symptoms As A Sequelae Of FeverCTRI/2023/07/055016I
招募中
2 期
A Clinical Trial To Evaluate The Action OF Duralabhadi Decoction In The Management Of Urinary Tract Infections.CTRI/2023/07/055121I
尚未招募
2 期
A clinical study to see the effectiveness of medicated oil administration through nose on nasal flora of healthy individualsCTRI/2023/07/055213Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
尚未招募
3 期
Effectiveness of Homoeopathic Medicine in treating Inflammatory Bowel DiseaseCTRI/2022/03/040881Anju KS